To deal with rising costs, employers are leveraging high performance networks, variable copay plans and exclusive provider ...

Over the past couple of years, ambient scribes have earned widespread adoption among health systems. While there's excitement ...

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

AHIP executives discussed the impact the proposed budget bill could have on Medicaid and the individual market.

If enacted, the GOP’s spending bill could kick more than 10 million Americans off Medicaid. Experts are worried about the ...

Arkansas became the first state to pass a law banning pharmacy benefit managers from owning pharmacies, aiming to curb their market power and reduce drug costs. But major PBMs like CVS and Express ...

CVS Caremark, Express Scripts and Optum Rx are fighting back. After the FTC filed a lawsuit in September, accusing the three major pharmacy benefit managers of engaging in anticompetitive rebating ...

During the early phases of the pandemic, nurses were quitting their jobs in droves, prompting major concerns about the future of the workforce as well as the healthcare industry’s reliance on ...

For gout pain that does not respond to conventional therapies, patients’ only remaining option is a drug from Amgen. But this biologic medicine introduces the same problem facing every ...

Optum is shutting down its virtual care business after a three-year run. Industry experts aren’t very surprised by the news. Healthcare leaders agree that this closure reflects broader trends in ...

Transplant surgeons are consistently battling against insurmountable odds in their pursuit to save lives. This especially comes to play with the most pressing challenge of all: the critical ...

Sales of Eli Lilly’s chronic weight management drug Zepbound are growing by leaps and bounds, but the product is expensive to manufacture and the pharmaceutical giant remains pressed to make ...